NASDAQ:VRPX   Virpax Pharmaceuticals, Inc.
One more COVID idea, could just grab some commons and wait to see if there is any merit to their Antiviral nasal spray. In on some commons at $4.40, will wait a few weeks to see if this catches any strength
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。